Apeloa

A leading pharmaceutical manufacturer in Hangzhou

Zhejiang Hengdian Apeloa, established in 1989, has grown into a major player in the pharmaceutical manufacturing sector. Based in the Shangcheng District of Hangzhou, the company operates under the Hengdian Group umbrella with over 7,000 employees worldwide.

Advanced facilities and capabilities

The company maintains seven manufacturing sites dedicated to active pharmaceutical ingredients, including five focused on chemical synthesis and two specialized in fermentation processes. Their cosmetic lab facilities are part of their extensive research and development infrastructure, supporting both pharmaceutical and cosmetic product development.

Research and development focus

With an R&D team exceeding 1,300 professionals and annual investment of over 5% of revenue, Zhejiang Hengdian Apeloa demonstrates its commitment to innovation. The company develops more than 15 new products annually for global regulatory submissions.

Global reach and market position

As China’s second-largest API exporter and a top 5 contract development and manufacturing organization (CDMO), the company maintains international operations with locations in:

• Multiple sites across China
• Tokyo, Japan
• Frankfurt, Germany
• Boston, USA

Quality and compliance standards

The company’s manufacturing facilities have successfully passed audits from major regulatory bodies since 2007, including:

• NMPA (National Medical Products Administration)
• US FDA
• EMEA (European Medicines Agency)
• PMDA (Pharmaceuticals and Medical Devices Agency, Japan)

Services and expertise

Operating from their Hangzhou headquarters, Zhejiang Hengdian Apeloa provides comprehensive services in drug development, biosynthesis, and chemical synthesis. Their product pipeline includes 50 products in various stages of development, serving pharmaceutical markets worldwide.